Concourse Financial Group Securities, Inc. Nuvation Bio Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding NUVB
# of Institutions
167Shares Held
156MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$48.3 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$28.6 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$24.3 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$18.4 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $404M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...